Comparison of patient-reported outcomes with quetiapine extended release and quetiapine immediate release in patients with stable schizophrenia - the eXtRa Study

被引：0

作者：

Riedel, M. ^{[1
]}

Schmitz, M. ^{[2
]}

Ostergaard, P. Kare

Ferrannini, L. ^{[3
]}

Franco, M. A. ^{[4
]}

Alfano, V. ^{[5
]}

Vansvik, E. Dencker ^{[6
]}

机构：

[1] Vinzenz von Paul Hosp, Rottweil, Germany

[2] Inst Psychosomat Med, Psychiatrist Off, Vienna, Austria

[3] ASL3, Dept Mental Hlth & Addict, Genoa, Italy

[4] Zamora Hosp, Dept Psychiat, Zamora, Spain

[5] Parthenope Univ, Dept Studies Inst & Territorial Syst, Naples, Italy

[6] AstraZeneca, Sodertalje, Sweden

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷

关键词：

D O I：

10.1016/S0924-977X(12)70523-0

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S339 / S339

页数：1

共 50 条

[1] Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
Moeller, Hans-Juergen
Johnson, Sunny
Mateva, Temenuzhka
Brecher, Martin
Svensson, Ola
Miller, Frank
Meulien, Didier
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (02) : 95 - 105
[2] Effects of extended release Quetiapine Fumarate (Quetiapine XR) on patient-reported outcomes in patients with Generalised Anxiety Disorder (GAD)
Svedater, H.
Endicott, J.
Locklear, J.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 44 - 44
[3] Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: A randomised, double-blind, crossover study (eXtRa)
Riedel, Michael
Schmitz, Margot
Ostergaard, Peter Kare
Ferrannini, Luigi
Franco, Manuel A.
Alfano, Vincenza
Vansvik, Eva Dencker
SCHIZOPHRENIA RESEARCH, 2015, 162 (1-3) : 162 - 168
[4] Quetiapine Extended Release In Schizophrenia
Baldwin, Claudine M.
Scott, Lesley J.
CNS DRUGS, 2009, 23 (03) : 261 - 269
[5] COST EFFECTIVENESS OF QUETIAPINE EXTENDED RELEASE COMPARED WITH QUETIAPINE IMMEDIATE RELEASE IN SCHIZOPHRENIC PATIENTS IN MEXICO
Pozo Urquizo, L.
Pizarro, M.
Soto, H.
Gonzalez, A.
Salazar, A.
Polanco, A. C.
VALUE IN HEALTH, 2012, 15 (07) : A339 - A339
[6] Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release
Figueroa, Carlos
Brecher, Martin
Hamer-Maansson, Jennifer E.
Winter, Helen
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (02): : 199 - 204
[7] Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
Endicott, Jean
Svedsaeter, Henrik
Locklear, Julie C.
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 301 - 311
[8] TOLERABILITY OF ONCE-DAILY EXTENDED RELEASE QUETIAPINE COMPARED TO QUETIAPINE IMMEDIATE RELEASE: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS IN SCHIZOPHRENIA
Edwards, S. J.
Korim, F.
VALUE IN HEALTH, 2008, 11 (06) : A582 - A582
[9] Continued efficacy and tolerability in clinically stable patients switched from quetiapine immediate release (IR) to quetiapine sustained release (SR)
Moeller, H. J.
Johnson, S.
Mateva, T.
Meulien, D.
Brecher, M.
Svensson, O.
Miller, F.
EUROPEAN PSYCHIATRY, 2007, 22 : S126 - S127
[10] TOLERABILITY OF ONCE-DAILY EXTENDED RELEASE QUETIAPINE COMPARED TO QUETIAPINE IMMEDIATE RELEASE IN THE TREATMENT OF ACUTE BIPOLAR DISORDER: AN ADJUSTED INDIRECT COMPARISON
Edwards, S. J.
Korim, F.
VALUE IN HEALTH, 2008, 11 (06) : A581 - A581

← 1 2 3 4 5 →